Soliris gMG

Shares of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) have lost more than 10 percent over the past year, but one analyst is confident enough to call for upside to the stock. The Analyst Credit Suisse's Martin Auster initiated coverage of Alexion Pharmaceuticals' stock with an Outperform...